Medical Affairs plays a crucial role in bridging the gap between science and business in the pharmaceutical and life sciences ...

Medical Affairs has become an increasingly critical function in the pharmaceutical and life sciences industries. Acting as ...

The Advanced Bipolar Direct Energy Devices Market is a rapidly evolving sector that has garnered significant attention due to its applications in healthcare, particularly in minimally invasive ...

Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief ...

Caidya, a leading global mid-sized CRO, today announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm ...

GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will ...

MIAMI, FLORIDA / ACCESSWIRE / January 13, 2025 / Accident Medical Group (AMG) proudly announces a major milestone in its mission to provide unparalleled personal injury care: enrolling 1,000 medical ...

Ainos invites robotics and humanoid companies to join Ainos Alliance and digitize smell SAN DIEGO, CA / ACCESSWIRE / January 13, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a pioneer of digitizing ...

POTOMAC, MD / ACCESSWIRE / January 13, 2025 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi will be participating in a ...

Rappta Therapeutics (“Rappta”), focused on developing first-in-class anti-cancer drugs activating protein phosphatase 2A (PP2A), today announces an exclusive global license agreement with SpringWorks ...

Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...